Literature DB >> 4307540

Transient neurological distrubances in disseminated sclerosis: a case report.

M Harrison, J I McGill.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4307540      PMCID: PMC496494          DOI: 10.1136/jnnp.32.3.230

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  4 in total

1.  Paroxysmal dysarthria and ataxia in multiple sclerosis; a report of 2 unusual cases.

Authors:  F ANDERMANN; J B COSGROVE; D LLOYD-SMITH; A M WALTERS
Journal:  Neurology       Date:  1959-04       Impact factor: 9.910

2.  [On the pharmacology of the antiepileptic 5-carbamyl-5H-dibenzo(b,f)azepine].

Authors:  W THEOBALD; H A KUNZ
Journal:  Arzneimittelforschung       Date:  1963-02

3.  Effect of some anticonvulsant drugs on the spinal trigeminal nucleus.

Authors:  G H Fromm; J M Killian
Journal:  Neurology       Date:  1967-03       Impact factor: 9.910

4.  Paroxysmal dysarthria and other transient neurological disturbances in disseminated sclerosis.

Authors:  M L Espir; S M Watkins; H V Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  1966-08       Impact factor: 10.154

  4 in total
  7 in total

1.  Paroxysmal brain stem dysfunction as presenting feature of multiple sclerosis.

Authors:  W H Perks; R G Lascelles
Journal:  Br Med J       Date:  1976-11-13

2.  La toux diabolique: neurogenic tussive crisis.

Authors:  D E Jacome
Journal:  Postgrad Med J       Date:  1985-06       Impact factor: 2.401

3.  Periodic ataxia: an unusual non-familial variation with paroxysmal EEG features.

Authors:  J Braham; T Siegal; M Sadeh
Journal:  J Neurol       Date:  1982       Impact factor: 4.849

4.  [Paroxysmal dysarthria and ataxia. A pathognomonic seizure syndrome in multiple sclerosis (author's transl)].

Authors:  P Wolf; H Assmus
Journal:  J Neurol       Date:  1974       Impact factor: 4.849

5.  Paroxysmal symptoms as the first manifestations of multiple sclerosis.

Authors:  J A Twomey; M L Espir
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-04       Impact factor: 10.154

6.  Treatment with acetazolamide of brain-stem and spinal paroxysmal disturbances in multiple sclerosis.

Authors:  V Voiculescu; B Pruskauer-Apostol; C Alecu
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-02       Impact factor: 10.154

7.  Treatment of paroxysmal disorders in multiple sclerosis with carbamazepine (Tegretol).

Authors:  M L Espir; P Millac
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-08       Impact factor: 10.154

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.